Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-13-006378
Filing Date
2013-11-14
Accepted
2013-11-14 10:35:19
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0913_actinium.htm 10-Q 670962
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE f10q0913ex31i_actinium.htm EX-31.1 19495
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECT f10q0913ex31ii_actinium.htm EX-31.2 19561
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO U.S.C. SECTION 1350 f10q0913ex32i_actinium.htm EX-32.1 8049
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO U.S. f10q0913ex32ii_actinium.htm EX-32.2 8430
  Complete submission text file 0001213900-13-006378.txt   4179065

Data Files

Seq Description Document Type Size
6 fil-20130930.xml EX-101.INS 551320
7 fil-20130930.xsd EX-101.SCH 46654
8 fil-20130930_cal.xml EX-101.CAL 24212
9 fil-20130930_def.xml EX-101.DEF 120334
10 fil-20130930_lab.xml EX-101.LAB 350315
11 fil-20130930_pre.xml EX-101.PRE 218549
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52446 | Film No.: 131217453
SIC: 6770 Blank Checks